BCR-ABL1 Kinase Domain Mutation (IRMA) by NGS
Utilizes next-generation sequencing (NGS) to identify mutations in the BCR-ABL kinase domain, which can impact the treatment of chronic myelogenous leukemia (CML). It informs treatment strategies.
Also known asbcr-abl1 kinase domain ngsbcr-abl1 irma ngsimatinib resistance testcml drug resistance sequencing
Available viaHome Collection, Lab Visit
GenderMale & Female
Contains1 parametersEarliest reports in17 Working Days
PreparationNo preparation needed
Test included
BCR-ABL1 Kinase Domain Mutation (IRMA) by NGS includes 1 parameter
- Specimen
Doctor information
Test code
G635
CPT and Loinc codes
Department
- Genexus Lab Category
Turn around time
17 Working Days
Test run frequency
Monday,Tuesday,Wednesday,Thursday,Friday,Saturday,Sunday TIME - 10:00
Performing locations
1 labs across India
Specimen vol. and vacutainer information
| Specimen | Vacutainer | Volume |
|---|---|---|
| Edta Whole Blood | Lavender Vacutainer | 3 ML |
Specimen stability information
Edta Whole Blood
BCR-ABL1 Kinase Domain Mutation (IRMA) by NGS test price for other cities
BCR-ABL1 Kinase Domain Mutation (IRMA) by NGS
Package price
₹11000
Need Help?
Talk to our health experts for guidance on tests, reports, or bookings.
WhatsApp to Book TestBCR-ABL1 Kinase Domain Mutation (IRMA) by NGS
₹11000